Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 362 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · derivative · entry 12

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 362 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 164 $271.68 $44,554.70
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · nonDerivative · entry 5

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,586

F11 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vested on 12/15/24.

F10 · balance_after: Includes 3,858 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 359 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · nonDerivative · entry 4

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 165 $271.68 $44,826.38
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · nonDerivative · entry 3

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,391

F11 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vested on 12/15/24.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 362 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,556

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 15:59 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 259 $271.68 $70,363.83
Disclosure

SEC source: 0001062993-24-020718 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,194

F11 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vested on 12/15/24.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 14:54 UTC
Smith GordonDirector
GrantHumana Common 765 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-018286 · form4.xml · nonDerivative · entry 1

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 765

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · shares: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 23:23 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 102 $320.19 $32,659.38
Disclosure

SEC source: 0001062993-24-017333 · form4.xml · derivative · entry 3

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 540

Underlying: Humana Common · 102 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
September 30, 2024 Filed Oct 2, 2024 23:23 UTC GrantRestricted Stock Units · Derivative 57 $320.19 $18,250.83
Disclosure

SEC source: 0001062993-24-017334 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296

Underlying: Humana Common · 57 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 23:22 UTC GrantRestricted Stock Units · Derivative 295 $320.19 $94,456.05
Disclosure

SEC source: 0001062993-24-017332 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,627

Underlying: Humana Common · 295 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 14:22 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionRestricted Stock Units · Derivative 1,241 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-016055 · form4.xml · derivative · entry 6

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 1,241 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 14:22 UTC
Renaudin George IIPresident, Medicare & Medicaid
Tax withholdingHumana Common 303 $352.14 $106,698.36
Disclosure

SEC source: 0001062993-24-016055 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,561

F11 · balance_after: Shares disposed of represent payment for tax liability for Restricted Stock vesting occurring on 9/1/24.

Read SEC document
September 01, 2024 Filed Sep 4, 2024 14:22 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionHumana Common 1,241 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-016055 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · balance_after: Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 22:49 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionRestricted Stock Units · Derivative 210 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-014377 · form4.xml · derivative · entry 3

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211

Underlying: Humana Common · 210 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 22:49 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 63 $357.33 $22,511.48
Disclosure

SEC source: 0001062993-24-014377 · form4.xml · nonDerivative · entry 2

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 860

F5 · shares: Shares disposed of represent payment for tax liability on restricted stock units vesting on 8/1/24.

F4 · balance_after: Includes 490 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 22:49 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 210 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-014377 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Includes 490 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 21:03 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 311 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-014375 · form4.xml · derivative · entry 9

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 311 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 21:03 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 142 $357.33 $50,740.15
Disclosure

SEC source: 0001062993-24-014375 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,960

F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 8/1/24.

F11 · balance_after: Includes 13,480 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
August 01, 2024 Filed Aug 2, 2024 21:03 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 311 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-014375 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · balance_after: Includes 13,480 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 13:57 UTC GrantRestricted Stock Units · Derivative 246 $379.29 $93,304.11
Disclosure

SEC source: 0001062993-24-013253 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,332

Underlying: Humana Common · 246 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 13:54 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 84 $379.29 $31,859.94
Disclosure

SEC source: 0001062993-24-013251 · form4.xml · derivative · entry 3

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438

Underlying: Humana Common · 84 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 13:50 UTC GrantRestricted Stock Units · Derivative 47 $379.29 $17,826.40
Disclosure

SEC source: 0001062993-24-013249 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239

Underlying: Humana Common · 47 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 15:46 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 92 $348.41 $32,054.16
Disclosure

SEC source: 0001062993-24-007548 · form4.xml · derivative · entry 3

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354

Underlying: Humana Common · 92 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 28, 2024 Filed Apr 1, 2024 15:45 UTC GrantRestricted Stock Units · Derivative 51 $348.41 $17,769.15
Disclosure

SEC source: 0001062993-24-007546 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192

Underlying: Humana Common · 51 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 15:44 UTC GrantRestricted Stock Units · Derivative 270 $348.41 $94,072.00
Disclosure

SEC source: 0001062993-24-007544 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,086

Underlying: Humana Common · 270 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 28, 2024 Filed Apr 1, 2024 14:18 UTC
Renaudin George IIPresident, Medicare & Medicaid
OtherPhantom Stock Units · Derivative 8 $346.72 $2,773.76
Disclosure

SEC source: 0001062993-24-007536 · form4.xml · derivative · entry 9

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 162

Underlying: Humana Common · 8 shares

Expires not disclosed

F10 · security: Phantom Stock Units held for the benefit of reporting person as of March 28, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F10 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 28, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F10 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 28, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F10 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 28, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F10 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 28, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 19:29 UTC
Fleming William KevinChief Corporate Aff. Officer
Tax withholdingHumana Common 1,226 $366.11 $448,844.73
Disclosure

SEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 2

Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,327

F15 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 19:29 UTC
Fleming William KevinChief Corporate Aff. Officer
Exercise / conversionHumana Common 3,566 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 1

Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · shares: Includes Performance Stock Units that are not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:21 UTC
Deshpande SamirChief Information Officer
Tax withholdingHumana Common 1,302 $366.11 $476,668.71
Disclosure

SEC source: 0001062993-24-004181 · form4.xml · nonDerivative · entry 2

Deshpande Samir · CIK 0001712481 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,396

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:21 UTC
Deshpande SamirChief Information Officer
Exercise / conversionHumana Common 3,770 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004181 · form4.xml · nonDerivative · entry 1

Deshpande Samir · CIK 0001712481 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · shares: Includes Performance Stock Units that are not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:10 UTC
BROUSSARD BRUCE DDirector · Chief Executive Officer
Tax withholdingHumana Common 8,473 $366.11 $3,102,007.67
Disclosure

SEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 2

BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,344

F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:10 UTC
BROUSSARD BRUCE DDirector · Chief Executive Officer
Exercise / conversionHumana Common 22,572 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 1

BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,817

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · shares: Includes Performance Stock Units that are not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:08 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Tax withholdingHumana Common 959 $366.11 $351,094.70
Disclosure

SEC source: 0001062993-24-004177 · form4.xml · nonDerivative · entry 2

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,886

F14 · shares: Disposition reported represents shares withheld for payment of tax liability on Performance Stock units vested on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 18:08 UTC
Agrawal VishalChief Strat & Corp Dev Officer
Exercise / conversionHumana Common 3,010 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004177 · form4.xml · nonDerivative · entry 1

Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:54 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 1,153 $366.11 $422,119.07
Disclosure

SEC source: 0001062993-24-004170 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,028

F13 · shares: Shares disposed of represent payment for tax liability on Performance Stock Units vested on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:54 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 3,411 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004170 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:52 UTC
Huval Timothy S.Chief Administrative Officer
Tax withholdingHumana Common 1,284 $366.11 $470,078.82
Disclosure

SEC source: 0001062993-24-004168 · form4.xml · nonDerivative · entry 2

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,390

F13 · shares: Shares disposed of represent payment for tax liability on Performance Stock Units vesting on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:52 UTC
Huval Timothy S.Chief Administrative Officer
Exercise / conversionHumana Common 3,712 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004168 · form4.xml · nonDerivative · entry 1

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · shares: Includes Performance Stock Units that are not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:09 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 1,125 $366.11 $411,868.13
Disclosure

SEC source: 0001062993-24-004158 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,311

F15 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Performance Stock Units on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 17:09 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 3,356 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004158 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,436

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 16:53 UTC
Renaudin George IIPresident, Medicare & Medicaid
Tax withholdingHumana Common 278 $366.11 $101,777.19
Disclosure

SEC source: 0001062993-24-004154 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,373

F13 · shares: Shares disposed of represent payment for tax liability on Performance Stock Units vesting on 2/22/24.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 16:53 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionHumana Common 1,104 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004154 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,651

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · shares: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:15 UTC
Rechtin James A.President & COO
GrantOptions · Derivative 15,772 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004244 · form4.xml · derivative · entry 4

Rechtin James A. · CIK 0002006065 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,772

Underlying: Humana Common · 15,772 shares

Expires 2031-02-21

F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:15 UTC
Rechtin James A.President & COO
GrantHumana Common 4,085 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004244 · form4.xml · nonDerivative · entry 2

Rechtin James A. · CIK 0002006065 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,085

F6 · shares: Restricted stock units granted to reporting person on 2/21/24.

F7 · balance_after: Includes 4,085 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 19:29 UTC
Fleming William KevinChief Corporate Aff. Officer
GrantOptions · Derivative 5,389 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004189 · form4.xml · derivative · entry 10

Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,389

Underlying: Humana Common · 5,389 shares

Expires 2031-02-21

F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F7 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 19:29 UTC
Fleming William KevinChief Corporate Aff. Officer
GrantHumana Common 1,396 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004189 · form4.xml · nonDerivative · entry 3

Fleming William Kevin · CIK 0001699801 · Chief Corporate Aff. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,723

F11 · shares: Restricted stock units granted to reporting person on 2/21/24.

F12 · balance_after: Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 19:27 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
GrantHumana Common 490 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004185 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713

F4 · shares: Restricted stock units granted to reporting person on 2/21/24.

F5 · balance_after: Includes 490 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 18:21 UTC
Deshpande SamirChief Information Officer
GrantOptions · Derivative 5,652 $0.00 Strike: $367.21 $0.00
Disclosure

SEC source: 0001062993-24-004181 · form4.xml · derivative · entry 8

Deshpande Samir · CIK 0001712481 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,652

Underlying: Humana Common · 5,652 shares

Expires 2031-02-21

F5 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

F5 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 18:21 UTC
Deshpande SamirChief Information Officer
GrantHumana Common 1,464 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004181 · form4.xml · nonDerivative · entry 3

Deshpande Samir · CIK 0001712481 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,860

F11 · shares: Restricted stock units granted to reporting person on 2/21/24.

F12 · balance_after: Includes 1,464 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2024 Filed Feb 23, 2024 18:10 UTC
BROUSSARD BRUCE DDirector · Chief Executive Officer
GrantHumana Common 21,786 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 3

BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,130

F8 · shares: Restricted stock units granted to reporting person on 2/21/24.

F9 · balance_after: Includes 21,786 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.